rs180177272
Variant summary
Our verdict is Pathogenic. The variant received 17 ACMG points: 17P and 0B. PS1PM1PM2PM5PP2PP3_StrongPP5_Moderate
The NM_000030.3(AGXT):c.823A>C(p.Ser275Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely pathogenic in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S275I) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000030.3 missense
Scores
Clinical Significance
Conservation
Publications
- alanine glyoxylate aminotransferase deficiencyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- primary hyperoxaluria type 1Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Myriad Women’s Health, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 17 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| AGXT | NM_000030.3 | c.823A>C | p.Ser275Arg | missense_variant | Exon 8 of 11 | ENST00000307503.4 | NP_000021.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD4 exome Cov.: 35
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
Primary hyperoxaluria Pathogenic:1
Variant summary: AGXT c.823A>C (p.Ser275Arg) results in a non-conservative amino acid change located in the Aminotransferase class V domain (IPR000192) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251318 control chromosomes. To our knowledge, no occurrence of c.823A>C in individuals affected with Primary Hyperoxaluria Type 1 has been reported. At least one publication reports experimental evidence evaluating an impact on protein function demonstrating a significant decrease in activity (Pittman_2012, Lage_2014). The following publications have been ascertained in the context of this evaluation (PMID: 24718375, 22923379, 19479957). ClinVar contains an entry for this variant (Variation ID: 204130). Based on the evidence outlined above, the variant was classified as likely pathogenic. -
Primary hyperoxaluria, type I Pathogenic:1
- -
Cardiac arrhythmia Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at